Kinetic and mechanistic analysis of the Escherichia coli ribD-encoded bifunctional deaminase-reductase involved in riboflavin biosynthesis

Maria L B Magalhães, Argyrides Argyrou, Sean M. Cahill, John S. Blanchard

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Riboflavin is biosynthesized by most microorganisms and plants, while mammals depend entirely on the absorption of this vitamin from the diet to meet their metabolic needs. Therefore, riboflavin biosynthesis appears to be an attractive target for drug design, since appropriate inhibitors of the pathway would selectively target the microorganism. We have cloned and solubly expressed the bifunctional ribD gene from Escherichia coli, whose three-dimensional structure was recently determined. We have demonstrated that the rate of deamination (370 min-1) exceeds the rate of reduction (19 min -1), suggesting no channeling between the two active sites. The reductive ring opening reaction occurs via a hydride transfer from the C 4-pro-R hydrogen of NADPH to C′-1 of ribose and is the rate-limiting step in the overall reaction, exhibiting a primary kinetic isotope effect (DV) of 2.2. We also show that the INH-NADP adduct, one of the active forms of the anti-TB drug isoniazid, inhibits the E. coli RibD. On the basis of the observed patterns of inhibition versus the two substrates, we propose that the RibD-catalyzed reduction step follows a kinetic scheme similar to that of its structural homologue, DHFR.

Original languageEnglish (US)
Pages (from-to)6499-6507
Number of pages9
JournalBiochemistry
Volume47
Issue number24
DOIs
StatePublished - Jun 17 2008

Fingerprint

Riboflavin
Biosynthesis
NADP
Microorganisms
Escherichia coli
Oxidoreductases
Deamination
Kinetics
Mammals
Ribose
Drug Design
Isoniazid
Nutrition
Vitamins
Hydrides
Isotopes
Pharmaceutical Preparations
Hydrogen
Catalytic Domain
Genes

ASJC Scopus subject areas

  • Biochemistry

Cite this

Kinetic and mechanistic analysis of the Escherichia coli ribD-encoded bifunctional deaminase-reductase involved in riboflavin biosynthesis. / Magalhães, Maria L B; Argyrou, Argyrides; Cahill, Sean M.; Blanchard, John S.

In: Biochemistry, Vol. 47, No. 24, 17.06.2008, p. 6499-6507.

Research output: Contribution to journalArticle

@article{4e6459dd7a464ca0b66276d2f6cab2be,
title = "Kinetic and mechanistic analysis of the Escherichia coli ribD-encoded bifunctional deaminase-reductase involved in riboflavin biosynthesis",
abstract = "Riboflavin is biosynthesized by most microorganisms and plants, while mammals depend entirely on the absorption of this vitamin from the diet to meet their metabolic needs. Therefore, riboflavin biosynthesis appears to be an attractive target for drug design, since appropriate inhibitors of the pathway would selectively target the microorganism. We have cloned and solubly expressed the bifunctional ribD gene from Escherichia coli, whose three-dimensional structure was recently determined. We have demonstrated that the rate of deamination (370 min-1) exceeds the rate of reduction (19 min -1), suggesting no channeling between the two active sites. The reductive ring opening reaction occurs via a hydride transfer from the C 4-pro-R hydrogen of NADPH to C′-1 of ribose and is the rate-limiting step in the overall reaction, exhibiting a primary kinetic isotope effect (DV) of 2.2. We also show that the INH-NADP adduct, one of the active forms of the anti-TB drug isoniazid, inhibits the E. coli RibD. On the basis of the observed patterns of inhibition versus the two substrates, we propose that the RibD-catalyzed reduction step follows a kinetic scheme similar to that of its structural homologue, DHFR.",
author = "Magalh{\~a}es, {Maria L B} and Argyrides Argyrou and Cahill, {Sean M.} and Blanchard, {John S.}",
year = "2008",
month = "6",
day = "17",
doi = "10.1021/bi800264g",
language = "English (US)",
volume = "47",
pages = "6499--6507",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "24",

}

TY - JOUR

T1 - Kinetic and mechanistic analysis of the Escherichia coli ribD-encoded bifunctional deaminase-reductase involved in riboflavin biosynthesis

AU - Magalhães, Maria L B

AU - Argyrou, Argyrides

AU - Cahill, Sean M.

AU - Blanchard, John S.

PY - 2008/6/17

Y1 - 2008/6/17

N2 - Riboflavin is biosynthesized by most microorganisms and plants, while mammals depend entirely on the absorption of this vitamin from the diet to meet their metabolic needs. Therefore, riboflavin biosynthesis appears to be an attractive target for drug design, since appropriate inhibitors of the pathway would selectively target the microorganism. We have cloned and solubly expressed the bifunctional ribD gene from Escherichia coli, whose three-dimensional structure was recently determined. We have demonstrated that the rate of deamination (370 min-1) exceeds the rate of reduction (19 min -1), suggesting no channeling between the two active sites. The reductive ring opening reaction occurs via a hydride transfer from the C 4-pro-R hydrogen of NADPH to C′-1 of ribose and is the rate-limiting step in the overall reaction, exhibiting a primary kinetic isotope effect (DV) of 2.2. We also show that the INH-NADP adduct, one of the active forms of the anti-TB drug isoniazid, inhibits the E. coli RibD. On the basis of the observed patterns of inhibition versus the two substrates, we propose that the RibD-catalyzed reduction step follows a kinetic scheme similar to that of its structural homologue, DHFR.

AB - Riboflavin is biosynthesized by most microorganisms and plants, while mammals depend entirely on the absorption of this vitamin from the diet to meet their metabolic needs. Therefore, riboflavin biosynthesis appears to be an attractive target for drug design, since appropriate inhibitors of the pathway would selectively target the microorganism. We have cloned and solubly expressed the bifunctional ribD gene from Escherichia coli, whose three-dimensional structure was recently determined. We have demonstrated that the rate of deamination (370 min-1) exceeds the rate of reduction (19 min -1), suggesting no channeling between the two active sites. The reductive ring opening reaction occurs via a hydride transfer from the C 4-pro-R hydrogen of NADPH to C′-1 of ribose and is the rate-limiting step in the overall reaction, exhibiting a primary kinetic isotope effect (DV) of 2.2. We also show that the INH-NADP adduct, one of the active forms of the anti-TB drug isoniazid, inhibits the E. coli RibD. On the basis of the observed patterns of inhibition versus the two substrates, we propose that the RibD-catalyzed reduction step follows a kinetic scheme similar to that of its structural homologue, DHFR.

UR - http://www.scopus.com/inward/record.url?scp=45749137952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749137952&partnerID=8YFLogxK

U2 - 10.1021/bi800264g

DO - 10.1021/bi800264g

M3 - Article

C2 - 18500821

AN - SCOPUS:45749137952

VL - 47

SP - 6499

EP - 6507

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 24

ER -